Literature DB >> 20538350

Type I interferon signals control Theiler's virus infection site, cellular infiltration and T cell stimulation in the CNS.

Young-Hee Jin1, Wanqiu Hou, Seung Jae Kim, Alyson C Fuller, Bongsu Kang, Gwen Goings, Stephen D Miller, Byung S Kim.   

Abstract

Theiler's murine encephalomyelitis virus (TMEV) establishes a persistent infection in the central nervous system (CNS). To examine the role of type I interferon (IFN-I)-mediated signals in TMEV infection, mice lacking a subunit of the type I IFN receptor (IFN-IR KO mice) were utilized. In contrast to wild type mice, IFN-IR KO mice developed rapid fatal encephalitis accompanied with greater viral load and infiltration of immune cells to the CNS. The proportion of virus-specific CD4(+) and CD8(+) T cell responses in the CNS was significantly lower in IFN-IR KO mice during the early stage of infection. Levels of IFN-γ and IL-17 produced by isolated primed CD4(+) T cells in response to DCs from TMEV-infected IFN-IR KO mice were also lower than those stimulated by DCs from TMEV-infected wild type control mice. The less efficient stimulation of virus-specific T cells by virus-infected antigen-presenting cells is attributable in part to the low level expression of activation markers on TMEV-infected cells from IFN-IR KO mice. However, due to high levels of cellular infiltration and viral loads in the CNS, the overall numbers of virus-specific T cells are higher in IFN-IR KO mice during the later stage of viral infection. These results suggest that IFN-I-mediated signals play important roles in controlling cellular infiltration to the CNS and shaping local T cell immune responses.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538350      PMCID: PMC2937062          DOI: 10.1016/j.jneuroim.2010.05.028

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  47 in total

1.  Natural adjuvants: endogenous activators of dendritic cells.

Authors:  S Gallucci; M Lolkema; P Matzinger
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

2.  Virus interference. I. The interferon.

Authors:  A ISAACS; J LINDENMANN
Journal:  Proc R Soc Lond B Biol Sci       Date:  1957-09-12

Review 3.  Interferon signalling network in innate defence.

Authors:  Akinori Takaoka; Hideyuki Yanai
Journal:  Cell Microbiol       Date:  2006-06       Impact factor: 3.715

4.  A critical function for type I interferons in cancer immunoediting.

Authors:  Gavin P Dunn; Allen T Bruce; Kathleen C F Sheehan; Vijay Shankaran; Ravindra Uppaluri; Jack D Bui; Mark S Diamond; Catherine M Koebel; Cora Arthur; J Michael White; Robert D Schreiber
Journal:  Nat Immunol       Date:  2005-06-12       Impact factor: 25.606

5.  De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.

Authors:  Stephen Mark Tompkins; Josette Padilla; Mauro C Dal Canto; Jenny P-Y Ting; Luc Van Kaer; Stephen D Miller
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

6.  Type I interferons produced by dendritic cells promote their phenotypic and functional activation.

Authors:  Maria Montoya; Giovanna Schiavoni; Fabrizio Mattei; Ion Gresser; Filippo Belardelli; Persephone Borrow; David F Tough
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

7.  Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3.

Authors:  Eui Young So; Min Hyung Kang; Byung S Kim
Journal:  Glia       Date:  2006-06       Impact factor: 7.452

8.  Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease.

Authors:  L C Pullen; S H Park; S D Miller; M C Dal Canto; B S Kim
Journal:  J Immunol       Date:  1995-11-01       Impact factor: 5.422

9.  Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells.

Authors:  Derek D C Ireland; Stephen A Stohlman; David R Hinton; Roscoe Atkinson; Cornelia C Bergmann
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

10.  Role of dendritic cells in differential susceptibility to viral demyelinating disease.

Authors:  Wanqiu Hou; Eui Young So; Byung S Kim
Journal:  PLoS Pathog       Date:  2007-08-24       Impact factor: 6.823

View more
  11 in total

1.  Melanoma differentiation-associated gene 5 is critical for protection against Theiler's virus-induced demyelinating disease.

Authors:  Young-Hee Jin; Seung Jae Kim; Eui Young So; Liping Meng; Marco Colonna; Byung S Kim
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

2.  The role of interleukin-6 in the expression of PD-1 and PDL-1 on central nervous system cells following infection with Theiler's murine encephalomyelitis virus.

Authors:  Young-Hee Jin; Wanqiu Hou; Hyun Seok Kang; Chang-Sung Koh; Byung S Kim
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

3.  TLR3 signaling is either protective or pathogenic for the development of Theiler's virus-induced demyelinating disease depending on the time of viral infection.

Authors:  Young-Hee Jin; Tomoki Kaneyama; Min Hyung Kang; Hyun Seok Kang; Chang-Sung Koh; Byung S Kim
Journal:  J Neuroinflammation       Date:  2011-12-21       Impact factor: 8.322

4.  Prostaglandin E2 produced following infection with Theiler's virus promotes the pathogenesis of demyelinating disease.

Authors:  Seung Jae Kim; Young-Hee Jin; Byung S Kim
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240

5.  Infection and Activation of B Cells by Theiler's Murine Encephalomyelitis Virus (TMEV) Leads to Autoantibody Production in an Infectious Model of Multiple Sclerosis.

Authors:  Young-Hee Jin; Charles X Kim; Jocelin Huang; Byung S Kim
Journal:  Cells       Date:  2020-07-27       Impact factor: 6.600

6.  C-type lectin receptor DCIR contributes to hippocampal injury in acute neurotropic virus infection.

Authors:  Melanie Stoff; Tim Ebbecke; Malgorzata Ciurkiewicz; Suvarin Pavasutthipaisit; Sabine Mayer-Lambertz; Theresa Störk; Kevin D Pavelko; Wolfgang Baumgärtner; Klaus Jung; Bernd Lepenies; Andreas Beineke
Journal:  Sci Rep       Date:  2021-12-10       Impact factor: 4.379

Review 7.  Excessive Innate Immunity Steers Pathogenic Adaptive Immunity in the Development of Theiler's Virus-Induced Demyelinating Disease.

Authors:  Byung S Kim
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

8.  Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced demyelinating disease.

Authors:  Lin Li; Reiner Ulrich; Wolfgang Baumgärtner; Ingo Gerhauser
Journal:  J Neuroinflammation       Date:  2015-12-24       Impact factor: 8.322

9.  Effects of Keratinocyte-Derived Cytokine (CXCL-1) on the Development of Theiler's Virus-Induced Demyelinating Disease.

Authors:  Min H Kang; Young H Jin; Byung S Kim
Journal:  Front Cell Infect Microbiol       Date:  2018-01-23       Impact factor: 5.293

10.  Rapid Expansion of Virus-Specific CD4+ T Cell Types in the CNS of Susceptible Mice Infected with Theiler's Virus.

Authors:  Hyun Seok Kang; Wanqiu Hou; Byung S Kim
Journal:  Int J Mol Sci       Date:  2020-10-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.